Postoperative risk of IDH-mutant glioma-associated seizures and their potential management with IDH-mutant inhibitors. Read more about Postoperative risk of IDH-mutant glioma-associated seizures and their potential management with IDH-mutant inhibitors.
Lysosomal lipid peroxidation mediates immunogenic cell death. Read more about Lysosomal lipid peroxidation mediates immunogenic cell death.
Astroglial toxicity promotes synaptic degeneration in the thalamocortical circuit in frontotemporal dementia with GRN mutations. Read more about Astroglial toxicity promotes synaptic degeneration in the thalamocortical circuit in frontotemporal dementia with GRN mutations.
Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects. Read more about Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects.
Chronic viral coinfections differentially affect the likelihood of developing long COVID. Read more about Chronic viral coinfections differentially affect the likelihood of developing long COVID.
Superenhancer activation of KLHDC8A drives glioma ciliation and hedgehog signaling. Read more about Superenhancer activation of KLHDC8A drives glioma ciliation and hedgehog signaling.
CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target. Read more about CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target.
Erythroid lineage Jak2V617F expression promotes atherosclerosis through erythrophagocytosis and macrophage ferroptosis. Read more about Erythroid lineage Jak2V617F expression promotes atherosclerosis through erythrophagocytosis and macrophage ferroptosis.
Breast cancer chemotherapy induces vascular dysfunction and hypertension through a NOX4-dependent mechanism. Read more about Breast cancer chemotherapy induces vascular dysfunction and hypertension through a NOX4-dependent mechanism.
Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer. Read more about Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer.
